Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm Study

Clinical trial NCT06516484 · UNKNOWN

Trial details

NCT number: NCT06516484
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Aplastic Anemia

Start date: 2024-07-30
Primary completion: 2025-07-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.